Timing of Introduction to Solid Food, Growth, and Nutrition Risk in Later Childhood

Curtis J D'Hollander1, Charles D G Keown-Stoneman2, Catherine S Birken3

  • 1Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada; Department of Paediatrics, St Michael's Hospital, Toronto, Ontario, Canada; Applied Health Research Centre, Unity Health Toronto, Toronto, Ontario, Canada.

The Journal of Pediatrics
|September 5, 2021
PubMed

Insights

Introducing infant cereal earlier, between 4 and 6 months, is linked to higher body mass index and obesity risk in children. These findings support delaying solid food introduction until around 6 months of age.

Area of Science:

  • Pediatric Nutrition
  • Childhood Growth and Development
  • Public Health

Background:

  • Early introduction of solid foods, including infant cereal, is a common practice.
  • The optimal timing for introducing complementary foods remains a subject of ongoing research and debate.
  • Understanding the long-term effects of infant feeding practices on child health is crucial.

Purpose of the Study:

  • To investigate the association between the timing of infant cereal introduction (4 vs. 6 months) and subsequent growth and dietary intake in children.
  • To determine if early introduction of infant cereal impacts body mass index (BMI), height, and eating behaviors later in childhood.
  • To provide evidence-based recommendations for infant feeding practices.

Main Methods:

  • A longitudinal cohort study involving 8,943 healthy children aged 0-10 years in Toronto, Canada.
  • Data collected between June 2008 and August 2019.
  • Analysis compared outcomes based on infant cereal introduction at 4 months versus 6 months of age.

Main Results:

  • Introduction of infant cereal at 4 months, compared to 6 months, was associated with a higher BMI z-score and increased odds of obesity at 10 years of age.
  • Early introduction at 4 months showed a higher height-for-age z-score at 1 year, but this difference was not sustained at 5 or 10 years.
  • Children introduced to infant cereal earlier exhibited a less favorable eating behavior score between 18 months and 5 years, indicating higher nutritional risk.

Conclusions:

  • Introducing infant cereal at 4 months versus 6 months is linked to adverse outcomes, including higher BMI, obesity risk, and poorer eating behaviors.
  • The findings support current recommendations to introduce solid foods, such as infant cereal, around 6 months of age.
  • Delayed introduction of infant cereal may contribute to better long-term growth and eating habits in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
36
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.2K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
42
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
47
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
41